ReviewNeuropsychiatric disease and treatment2019

Examining the safety, efficacy, and patient acceptability of inhaled loxapine for the acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults.

Justin Faden et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.